Supriya Announce Agreement To Market Plasma Nutrition’s IoProtein In India

Mumbai : API company Supriya Lifescience has announced a recent collaboration with Plasma Nutrition, a US-based nutrition company located in Delaware.

The strategic partnership involves an exclusive technology licensing agreement, granting Supriya Lifescience the sole rights for manufacturing and marketing Ingredient Optimised Protein (ioProtein) in India.

The primary purpose of this collaboration is to bring the optimised protein into the Indian market. ioProtein is a patented process (patent pending in the US) This revolutionary protein powder is designed for use as protein supplements and boasts a significant advantage, and it is highly bioavailable. This means that higher amounts of proteins are absorbed quickly by the body, providing consumers with a more effective and efficient protein supplement.

During the term of the agreement, Supriya Lifescience will lead the manufacturing and marketing of ioProtein in India. This marks the introduction of a new category of protein powders in the Indian market, and it is relatively healthier compared to other popular protein powders available through various gyms, general stores, and digital marketing channels.

“We are thrilled to be the exclusive partner of Plasma Nutrition, in introducing the innovative ioProtein to the Indian market,” said Dr Saloni Wagh, Executive Director at Supriya Lifescience.

“This strategic partnership represents our commitment to providing high-nutrition solutions to consumers in India. With ioProtein’s high bioavailability and its unmatched advantage, we are confident that the ‘IO’ technology will revolutionise the nutrition industry and become the preferred choice for health-conscious individuals,” Dr Wagh added.

“We are excited to collaborate with Supriya Lifescience and bring our patented ioProtein technology to India,” said Chris Flynn-Rozanski, co-founder & CEO at Plasma Nutrition.

“India’s rapidly growing demand for protein supplements present an excellent opportunity for us to introduce this highly bioavailable protein powder, which has already been well-received in other markets. We believe this partnership will create a new standard for protein supplementation in India,” Flynn-Rozanski said.

Related Posts

  • Pharma
  • November 21, 2024
  • 103 views
India’s First Indigenous Antibiotic ‘Nafithromycin’ For Resistant Infections Is Launched

New Delhi:  In a ground breaking step for India’s biotechnology sector, Union Minister Dr. Jitendra Singh today formally launched the first indigenous antibiotic “Nafithromycin” for resistant infections. It is only…

  • Pharma
  • November 21, 2024
  • 119 views
Stock Of Expired Veterinary Drugs Seized In Mahabubabad

Hyderabad: Officials from the Drugs Control Administration (DCA), Telangana, found illegally stocked veterinary drugs that included expired drugs, physicians’ samples, and institutional supply drugs during raids at an unlicensed premise in…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s First Indigenous Antibiotic ‘Nafithromycin’ For Resistant Infections Is Launched

India’s First Indigenous Antibiotic ‘Nafithromycin’ For Resistant Infections Is Launched

Stock Of Expired Veterinary Drugs Seized In Mahabubabad

Stock Of Expired Veterinary Drugs Seized In Mahabubabad

Drug Licenses Of Medical Stores In Villages Without Hospitals Will Be Cancelled

Drug Licenses Of Medical Stores In Villages Without Hospitals Will Be Cancelled

Promethazine Hydrochloride (Phenergan) Should Not Be Given To Children Under 6: TGA

Promethazine Hydrochloride (Phenergan) Should Not Be Given To Children Under 6: TGA

2 Arrested With Narcotic Injections Worth Rs 1.85 Lakh, One Absconding

2 Arrested With Narcotic Injections Worth Rs 1.85 Lakh, One Absconding

Smuggler Arrested With 1600 Narcotic Injections

Smuggler Arrested With 1600 Narcotic Injections